BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36807391)

  • 1. Suppression of fatty acid oxidation supports pancreatic cancer growth and survival under hypoxic conditions through autophagy induction.
    Kim B; Gwak J; Kim M; Yang S; Hwang S; Shin S; Kim JH; Son J; Jeong SM
    Cancer Gene Ther; 2023 Jun; 30(6):878-889. PubMed ID: 36807391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and pancreatic ductal adenocarcinoma.
    Yamasaki A; Yanai K; Onishi H
    Cancer Lett; 2020 Aug; 484():9-15. PubMed ID: 32380129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.
    Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition.
    Li X; Roife D; Kang Y; Dai B; Pratt M; Fleming JB
    Oncogene; 2016 Sep; 35(37):4881-90. PubMed ID: 26876211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
    Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
    Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia and Serum deprivation protected MiaPaCa-2 cells from KAI1-induced proliferation inhibition through autophagy pathway activation in solid tumors.
    Wu CY; Guo XZ; Li HY
    Clin Transl Oncol; 2015 Mar; 17(3):201-8. PubMed ID: 25199507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development.
    Jia Y; Li HY; Wang Y; Wang J; Zhu JW; Wei YY; Lou L; Chen X; Mo SJ
    Int J Biol Sci; 2021; 17(11):2772-2794. PubMed ID: 34345207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
    Tu Q; Liu X; Yao X; Li R; Liu G; Jiang H; Li K; Chen Q; Huang X; Chang Q; Xu G; Zhu H; Shi P; Zhao B
    J Exp Clin Cancer Res; 2022 Sep; 41(1):274. PubMed ID: 36109793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid oxidation supports melanoma cell migration through autophagy regulation.
    Shin S; Yang S; Kim M; Lee EK; Hur SC; Jeong SM
    Biochem Biophys Res Commun; 2023 Sep; 674():124-132. PubMed ID: 37419033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas.
    Zhuang H; Wang S; Chen B; Zhang Z; Ma Z; Li Z; Liu C; Zhou Z; Gong Y; Huang S; Hou B; Chen Y; Zhang C
    Front Immunol; 2021; 12():790661. PubMed ID: 34925373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy.
    Saliakoura M; Sebastiano MR; Nikdima I; Pozzato C; Konstantinidou G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):16. PubMed ID: 34998392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway.
    Sun L; Hu L; Cogdell D; Lu L; Gao C; Tian W; Zhang Z; Kang Y; Fleming JB; Zhang W
    Autophagy; 2017 Apr; 13(4):703-714. PubMed ID: 28121485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer.
    Thakur PC; Miller-Ocuin JL; Nguyen K; Matsuda R; Singhi AD; Zeh HJ; Bahary N
    J Transl Med; 2018 Jul; 16(1):190. PubMed ID: 29986726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.
    Reyes-Castellanos G; Abdel Hadi N; Carrier A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is targeting autophagy a promising lead to unveil the cloak of invisibility in pancreatic cancer?
    Cayron C; Rigal S; Guillermet-Guibert J
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101622. PubMed ID: 33770630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagy as a therapeutic strategy against pancreatic cancer.
    Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K; Fujishiro M
    J Gastroenterol; 2022 Sep; 57(9):603-618. PubMed ID: 35727403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation.
    Toshima T; Shirabe K; Matsumoto Y; Yoshiya S; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    J Gastroenterol; 2014 May; 49(5):907-16. PubMed ID: 23702609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.